美国 · 平台与数据 · Finviz
Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially…
在 Finviz 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (finviz.com)
